231 related articles for article (PubMed ID: 1318410)
1. Identification of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant vaccinia virus.
Rapp M; Messerle M; Bühler B; Tannheimer M; Keil GM; Koszinowski UH
J Virol; 1992 Jul; 66(7):4399-406. PubMed ID: 1318410
[TBL] [Abstract][Full Text] [Related]
2. Expression of the murine cytomegalovirus glycoprotein H by recombinant vaccinia virus.
Rapp M; Lucin P; Messerle M; Loh LC; Koszinowski UH
J Gen Virol; 1994 Jan; 75 ( Pt 1)():183-8. PubMed ID: 8113726
[TBL] [Abstract][Full Text] [Related]
3. Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus.
Cranage MP; Kouzarides T; Bankier AT; Satchwell S; Weston K; Tomlinson P; Barrell B; Hart H; Bell SE; Minson AC
EMBO J; 1986 Nov; 5(11):3057-63. PubMed ID: 3024973
[TBL] [Abstract][Full Text] [Related]
4. Identification and molecular characterization of the murine cytomegalovirus homolog of the human cytomegalovirus UL100 gene.
Li W; Eidman K; Gehrz RC; Kari B
Virus Res; 1995 May; 36(2-3):163-75. PubMed ID: 7653096
[TBL] [Abstract][Full Text] [Related]
5. Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response.
Britt WJ; Vugler L; Butfiloski EJ; Stephens EB
J Virol; 1990 Mar; 64(3):1079-85. PubMed ID: 2154594
[TBL] [Abstract][Full Text] [Related]
6. Sequence analysis and expression of the murine cytomegalovirus phosphoprotein pp50, a homolog of the human cytomegalovirus UL44 gene product.
Loh LC; Britt WJ; Raggo C; Laferté S
Virology; 1994 May; 200(2):413-27. PubMed ID: 8178431
[TBL] [Abstract][Full Text] [Related]
7. Assessment of antigenicity and genetic variation of glycoprotein B of murine cytomegalovirus.
Xu J; Lyons PA; Carter MD; Booth TW; Davis-Poynter NJ; Shellam GR; Scalzo AA
J Gen Virol; 1996 Jan; 77 ( Pt 1)():49-59. PubMed ID: 8558128
[TBL] [Abstract][Full Text] [Related]
8. High expression of human cytomegalovirus (HCMV)-gB protein in cells infected with a vaccinia-gB recombinant: the importance of the gB protein in HCMV immunity.
Gönczöl E; deTaisne C; Hirka G; Berencsi K; Lin WC; Paoletti E; Plotkin S
Vaccine; 1991 Sep; 9(9):631-7. PubMed ID: 1659051
[TBL] [Abstract][Full Text] [Related]
9. Cloning, characterization, and expression of the murine cytomegalovirus homologue of the human cytomegalovirus 28-kDa matrix phosphoprotein (UL99).
Cranmer LD; Clark C; Spector DH
Virology; 1994 Dec; 205(2):417-29. PubMed ID: 7975245
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the murine cytomegalovirus genes encoding the major DNA binding protein and the ICP18.5 homolog.
Messerle M; Keil GM; Schneider K; Koszinowski UH
Virology; 1992 Nov; 191(1):355-67. PubMed ID: 1329325
[TBL] [Abstract][Full Text] [Related]
11. Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.
Chiuppesi F; Nguyen J; Park S; Contreras H; Kha M; Meng Z; Kaltcheva T; Iniguez A; Martinez J; La Rosa C; Wussow F; Diamond DJ
J Virol; 2018 Oct; 92(19):. PubMed ID: 30045984
[TBL] [Abstract][Full Text] [Related]
12. Identification of the glycoprotein H gene of murine cytomegalovirus.
Xu J; Dallas PB; Lyons PA; Shellam GR; Scalzo AA
J Gen Virol; 1992 Jul; 73 ( Pt 7)():1849-54. PubMed ID: 1321219
[TBL] [Abstract][Full Text] [Related]
13. DNA sequence and transcriptional analysis of the glycoprotein M gene of murine cytomegalovirus.
Scalzo AA; Forbes CA; Davis-Poynter NJ; Farrell HE; Lyons PA
J Gen Virol; 1995 Nov; 76 ( Pt 11)():2895-901. PubMed ID: 7595401
[TBL] [Abstract][Full Text] [Related]
14. Identification of the gene coding for rhesus cytomegalovirus glycoprotein B and immunological analysis of the protein.
Kropff B; Mach M
J Gen Virol; 1997 Aug; 78 ( Pt 8)():1999-2007. PubMed ID: 9267000
[TBL] [Abstract][Full Text] [Related]
15. Cloning and characterization of the guinea pig cytomegalovirus glycoprotein B gene.
Schleiss MR
Virology; 1994 Jul; 202(1):173-85. PubMed ID: 8009831
[TBL] [Abstract][Full Text] [Related]
16. Recombinant modified vaccinia virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirus.
Wang Z; La Rosa C; Maas R; Ly H; Brewer J; Mekhoubad S; Daftarian P; Longmate J; Britt WJ; Diamond DJ
J Virol; 2004 Apr; 78(8):3965-76. PubMed ID: 15047812
[TBL] [Abstract][Full Text] [Related]
17. Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage.
Spaete RR; Thayer RM; Probert WS; Masiarz FR; Chamberlain SH; Rasmussen L; Merigan TC; Pachl C
Virology; 1988 Nov; 167(1):207-25. PubMed ID: 2460994
[TBL] [Abstract][Full Text] [Related]
18. Induction of complement-dependent and -independent neutralizing antibodies by recombinant-derived human cytomegalovirus gp55-116 (gB).
Britt WJ; Vugler L; Stephens EB
J Virol; 1988 Sep; 62(9):3309-18. PubMed ID: 2841483
[TBL] [Abstract][Full Text] [Related]
19. Identification, sequencing and expression of the glycoprotein L gene of murine cytomegalovirus.
Xu J; Scalzo AA; Lyons PA; Farrell HE; Rawlinson WD; Shellam GR
J Gen Virol; 1994 Nov; 75 ( Pt 11)():3235-40. PubMed ID: 7964634
[TBL] [Abstract][Full Text] [Related]
20. Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type 1 glycoprotein H.
Cranage MP; Smith GL; Bell SE; Hart H; Brown C; Bankier AT; Tomlinson P; Barrell BG; Minson TC
J Virol; 1988 Apr; 62(4):1416-22. PubMed ID: 2831402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
